“…Benzothiazoles were investigated on several instances for their anti-cancer activity. 18,19,20,21,22,23,24,25,26 They were tested against selected number of cell lines, e.g., human cervical cancer, liver cancer, NSCL, prostate cancer, and human breast cancer exhibiting good to excellent antiproliferative activity with low toxicity. Former clinical candidate, Phortress (6), lysylamide prodrug of C(2) and C(6) substituted benzothiazole 5F203 (5), Figure 1)…”